Wake Forest Baptist Health in the US significantly extends its RayStation installation
The Comprehensive Cancer Center at Wake Forest Baptist Health in Winston-Salem, North Carolina, US, has placed an order for additional RayStation treatment planning systems, thereby significantly extending its existing installation. Going forward, RayStation will be the center’s primary treatment planning system.
The Comprehensive Cancer Center at Wake Forest Baptist Health, one of only 47 cancer centers in the US designated as comprehensive by the National Cancer Institute (NCI), has a long history of providing the best cancer care available, including radiation therapy, chemotherapy and surgery.
The RayStation order comprises a broad range of functionality, including planning support for IMRT, VMAT and advanced functionalities such as multi-criteria optimization and deformable registration.
Johan Löf, CEO of RaySearch, says: "We are very pleased to meet the needs of the highly considered Wake Forest Baptist Health, who provide world-class cancer care. Comprehensive cancer care is what RaySearch strive for and we look forward to the extended collaboration and to see what we can achieve together with Wake Forest Baptist Health.”
The systems of this order have been delivered and is will generate revenue in the second quarter of 2018.
About Comprehensive Cancer Center at Wake Forest Baptist
The Comprehensive Cancer Center has a long history of providing the best cancer care available, in a caring and compassionate manner. Wake Forest Baptist has proudly held the NCI designation since 1974 and NCI comprehensive designation since 1990, ensuring that all patients have access to the latest treatments, technologies and clinical trials.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00